SCHEMBL4348965

SCHEMBL4348965

O=C(NCCc1ccccc1)N(S)c1ccc(O)cc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 3/20 0.47
MMP2 P08253 3/20 0.47
MMP9 P14780 3/20 0.47
OPRM1 P35372 1/20 0.46
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
TRPV1 Q8NER1 2/20 0.45
SYK P43405 2/20 0.45
ARG1 P05089 1/20 0.44
PLAAT3 P53816 1/20 0.44
PLAAT5 Q96KN8 1/20 0.44
PLAAT2 Q9NWW9 1/20 0.44
PLAAT4 Q9UL19 1/20 0.44
MAPT P10636 2/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAOB P27338 1/20 0.44
SNCA P37840 1/20 0.44
ALDH1A1 P00352 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4345395 0.80 CA1 (0.49) TRPV1PLAAT3PLAAT5PLAAT2PLAAT4
SCHEMBL4348991 0.77 NAAA (0.52) TRPV1SYKMAPTMAOB
SCHEMBL4346354 0.77 RAB9A (0.46) MMP1MMP2OPRM1OPRD1OPRK1
SCHEMBL4343959 0.76 MAOA (0.45) MMP1MMP2MMP9TRPV1MAPT
SCHEMBL4351442 0.76 CA1 (0.45) PLAAT3PLAAT5PLAAT2PLAAT4MAPT
SCHEMBL4356059 0.75 NPC1 (0.50) PLAAT3PLAAT5PLAAT2PLAAT4MAPT
SCHEMBL4355899 0.75 RAB9A (0.53) MMP1MMP2PLAAT3PLAAT5PLAAT2
SCHEMBL4350095 0.75 MAPT (0.46) TRPV1PLAAT3PLAAT5PLAAT2PLAAT4
SCHEMBL4349030 0.75 RAB9A (0.49) MMP1MMP2OPRM1OPRD1OPRK1
SCHEMBL4347111 0.74 CA2 (0.58) MMP1MMP2MMP9OPRK1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 MMP1 4009/4885MMP2 2697/4885MMP9 3240/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 MMP1 3284/4885MMP2 1259/4885MMP9 2443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.